Radiation treatment for patients with intermediate-risk prostate cancer

David E. Greene, Jyoti S. Mayadev, Richard K Valicenti

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.

Original languageEnglish (US)
Pages (from-to)113-124
Number of pages12
JournalTherapeutic Advances in Urology
Issue number3
StatePublished - Jun 2012


  • androgen deprivation
  • brachytherapy
  • dose escalation
  • external beam
  • intermediate risk
  • outcomes
  • prostate cancer
  • radiation
  • review

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Radiation treatment for patients with intermediate-risk prostate cancer'. Together they form a unique fingerprint.

Cite this